Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue

Author： Schoffski P.   Herr A.   Vermorken J.B.   Van den Brande J.   Beijnen J.H.   Rosing H.   Volk J.   Ganser A.   Adank S.   Botma H.J.   Wanders J.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.38, Iss.6, 2002-01, pp. : 807-813

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation

By Fabi Alessandra  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 717-725

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere

By Soares Heloisa   Bayraktar Soley   Blaya Marcelo   Lopes Gilberto   Merchan Jaime   Macintyre Jessica   Mayo Carlos   Green Mark   Silva Orlando   Levi Joe   Walker Gail   Rocha-Lima Caio  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 839-845

Springer Publishing Company

Access to resources Recommend Favorite

A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer

By Yeo Chang   Lee Sang   Kim Ju   Kim Seung   Kim Seok   Kim Young   Kang Hyeon   Yoon Hyung   Song Jeong   Moon Hwa   Kim Jin   Kim Kwan   Shim Byoung   Kim Chi  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 809-814

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer

By Kerbrat P.   Dieras V.   Pavlidis N.   Ravaud A.   Wanders J.   Fumoleau P.   For the EORTC Early Clinical Studies Group/New Drug Development Office  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 317-320

Elsevier

Access to resources Recommend Favorite

A randomized phase II non-comparative study of pemetrexedcarboplatin and gemcitabinevinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients

By                    

International Journal of Oncology, Vol. 42, Iss. 5, 2013-01 ,pp. : 1778-1785

Spandidos Publications

Access to resources Recommend Favorite